Sponsored by:

Video from ECR 2015: Thomas Beyer, PhD, on hybrid imaging

Mar 5, 2015
Latest in Nuclear Medicine
New H3 Tracers Thumbnail
SNMMI: New PET tracers developed for imaging brain disorders
June 21, 2025
Alzheimer's Case Study
Sponsored
Alzheimer's Case Study
June 6, 2025
Money Pile 400
Positrigo closes $8.5M funding round
June 10, 2025
Pxl 20250531 175048475~2
Radium-223 safety confirmed in long-term study
June 2, 2025
Related Stories
2015 02 26 13 13 14 983 2015 03 04 Ecr Today Antoch Esophageal Cancer Post Therapy 20150226201338
Nuclear Medicine
Hybrid techniques make giant strides in clinical practice
2015 02 19 17 31 35 343 Petct Fifth Image Jnm 200
Nuclear Medicine
Multiple FDG-PET/CT scans can influence lung cancer treatment
2015 02 12 17 29 35 546 Pet Amyvid Thumbnail 200
Nuclear Medicine
U.S. SPECT, PET radiopharma market shows promise amid challenges
Alzheimer's Case Study
Sponsor Content
Alzheimer's Case Study
More in Nuclear Medicine
SNMMI: New PET tracers developed for imaging brain disorders
By Will Morton
Two newly developed PET imaging agents are effective for identifying a highly expressed receptor in neurological and psychiatric conditions.
June 21, 2025
New H3 Tracers Thumbnail
Ratio Therapeutics partners with Macrocyclics
By AuntMinnie.com staff writers
The agreement will enable access to Macropa in Japan, Canada, Australia, and a majority of Europe, according to Ratio.
June 13, 2025
Ame 2018 12 11 00 02 7009 Atom Nuclear Lab 400
Positrigo closes $8.5M funding round
By AuntMinnie.com staff writers
Firm also notes board changes.
June 10, 2025
Money Pile 400
Radium-223 safety confirmed in long-term study
By Erik L. Ridley
At ASCO 2025, researchers shared data on the long-term safety of Ra-223 treatments for metastatic castration-resistant prostate cancer.
June 2, 2025
Pxl 20250531 175048475~2
Clarity highlights first patient imaged in Amplify trial
By AuntMinnie.com staff writers
Clarity Pharmaceuticals has imaged the first patient in its phase III Amplify trial at XCancer in Omaha, NE.
May 29, 2025
Prostate Cancer 3 D Rendering 400 (1)
ITM forges $263M debt financing agreement
By AuntMinnie.com staff writers
Isotope Technologies Munich (ITM) has entered into a debt financing agreement for up to $262.5 million.
May 28, 2025
Isotopes1
ISMRM: AI spots ischemic heart disease on low GBCA dose images
By Erik L. Ridley
An AI-based framework was highly accurate for detecting myocardial ischemia, even on images acquired with 90% less gadolinium.
May 14, 2025
Representative stress perfusion CMR case with 80% contrast dose reduction. Pixel-wise MBF maps and AHA 16-segment bull's eye plots are shown for full-dose and reduced-dose acquisitions. When analyzed using the proposed MST deep learning method, the reduced-dose data closely matches the full-dose data across basal, mid, and apical slices. In contrast, Fermi-deconvolution shows good agreement in apical and mid slices but overestimates MBF in some basal segments, indicating reduced accuracy under low-dose conditions. Image courtesy of the ISMRM.
FDA clears GE's new dual-head SPECT/CT system
By AuntMinnie.com staff writers
The U.S. Food and Drug Administration (FDA) has cleared GE HealthCare's (GEHC) new dual-head SPECT/CT system, Aurora.
May 5, 2025
Gehc
Controversy clouds nuclear medicine bill
By Will Morton
Radiology societies and patient advocates are at odds over a bill in the U.S. Congress.
May 1, 2025
Congress
ARRS: 'Neurotheranostics' may be new frontier for nuclear medicine
By Will Morton
Advances in brain PET imaging combined with new treatments for Alzheimer’s have given rise to a new concept of "neurotheranostics."
April 29, 2025
A conceptual framework for neurotheranostics.
ARRS: Rib uptake evaluation on F-18 DCFPyL PET/CT presents challenges
By Maryam Payne
Evaluating increased rib uptake on F-18 DCFPyL PET/CT in prostate cancer patients may lead to false positives.
April 28, 2025
Pet Ct Machine
Eckert & Ziegler signs manufacturing deal with Pentixapharm
By AuntMinnie.com staff writers
Eckert & Ziegler Radiopharma GmbH has signed a manufacturing agreement with Pentixapharm.
April 24, 2025
Manufacturing Facility Process
Page 1 of 438
Next Page